Home
About
Overview
Sharing Data
ORCID
Help
History (92)
Enhancement of the activity of cefotaxime by iron-binding proteins.
A trifluoroacetic acid-labile sulfonate protecting group and its use in the synthesis of a near-IR fluorophore.
In vivo function and membrane binding properties are correlated for Escherichia coli lamB signal peptides.
Microtechnology
HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.
See All 92 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.
Moonis M, Fisher M. HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke. Expert Rev Neurother. 2004 Mar; 4(2):241-7.
View in:
PubMed
subject areas
Animals
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Randomized Controlled Trials as Topic
Stroke
Treatment Outcome
authors with profiles
Majaz Moonis MD